NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum...
The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no...
Phase 1b/2a trial of NervGen’s lead compound, NVG-291, is based upon unprecedented, peer-reviewed animal studies demonstrating pronounced functional recovery from spinal cord injury “The ability...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN; OTCQX:...
American Stock Exchange to Trade Options on Four Securities NEW YORK, Jan. 9 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Monday, January 12, 2004...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.4 | 18.1818181818 | 2.2 | 2.72 | 2.05 | 87719 | 2.22385008 | CS |
4 | 0.19 | 7.88381742739 | 2.41 | 2.8 | 2.05 | 55249 | 2.39829619 | CS |
12 | -0.26 | -9.09090909091 | 2.86 | 2.87 | 2.05 | 43522 | 2.4549283 | CS |
26 | 0.46 | 21.4953271028 | 2.14 | 3.31 | 1.65 | 62468 | 2.57307033 | CS |
52 | 0.65 | 33.3333333333 | 1.95 | 3.98 | 1.58 | 70907 | 2.55418954 | CS |
156 | -0.21 | -7.47330960854 | 2.81 | 3.98 | 1.5 | 43236 | 2.32112644 | CS |
260 | 0.96 | 58.5365853659 | 1.64 | 3.98 | 0.8 | 39967 | 2.25664996 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales